The 2nd HPD report - Health Policy Monitor

More documents

Recommendations

Info

Idea Pilot Policy Paper Legislation Adoption Evaluation Change In 1998 a change in government opened a window of opportunity to realize this long-overdue reform of the South Korean health care system. Upon an initiative of progressive academics, the scientific community and to some extent civic groups, the government tackled the problem of separating the prescription of drugs from the dispensing of drugs. Against the massive resistance of physicians and the much weaker opposition of pharmacists, the reform went through. Widespread strikes by physicians forced the government to amend the draft (e.g., by dropping measures promoting prescription of generics). As a result, the reform is expected to lead physicians to prescribe high-quality expensive drugs, thus reducing the potential savings. Sources and further reading: Kwon, Soonman. “Pharmaceutical reform and physician strikes in Korea: Separation of drug prescribing and dispensing.” Social Science and Medicine 57 2003, 529–538. Kwon, Soonman and Michael Reich. “The Changing Process and Politics of Health Policy in Korea.” Working Paper, Harvard Center for Population and Development, October 2003 (www.hsph.harvard.edu/hcpds/wpweb/ Kwon%20wp1310.pdf). 65 Policy change: Unique chance for cutting expenditure and drug misuse No generic prescription
Public Visibility Impact Transferability New Zealand: Direct-to-consumer advertising of prescription medicines In February 2003, a group of leading general practitioners prepared a report on direct-to-consumer advertising (DTCA) and presented it to the government. The flash point: Patients increasingly pressured their physicians to prescribe so-called “life-style pharmaceuticals,” such as drugs against obesity or male impotence. Data show that expenditure on these drugs has increased quite significantly. Idea Pilot Policy Paper Legislation Adoption Evaluation Change However, there is little likelihood that this report will trigger any relevant response. When the DTCA policy was reviewed in 2000/2001, public consultations showed a slight majority in favor of DTCA. Therefore the government did not modify its policy. Instead, it encouraged the pharmaceutical industry to strengthen its rules and Code of Practice. Except for the US, New Zealand is the only country in the world allowing direct-to-consumer advertising of prescription medicines. The European Parliament recently rejected a proposal that would have paved the way for DTCA in Europe. 66 Sources and further reading: www.chmeds.ac.nz/report.pdf www.pharmac.govt.nz/pdf/150903a.pdf www.pharmac.govt.nz/stat.asp www.rmianz.co.nz/html/views/gpweek/2003/100903.htm
Page 1 and 2:
Reinhard Busse, Sophia Schlette (ed
Page 4 and 5:
Reinhard Busse, Sophia Schlette (ed
Page 6 and 7:
Contents Editorial ................
Page 8:
Newsflash .........................
Page 11 and 12:
Partner institutions were selected
Page 13 and 14:
- Relevance and scope - Impact on s
Page 15 and 16: The figure below illustrates a poli
Page 18 and 19: Introduction This second issue of
Page 20 and 21: the extent to which private financi
Page 22 and 23: Health and Aging Long life expectan
Page 24 and 25: To address such a broad spectrum of
Page 26 and 27: The “National Strategy for an Age
Page 28 and 29: Finally, the reform introduces pers
Page 30 and 31: Idea Pilot Policy Paper Legislation
Page 32 and 33: Sources and further reading: Depart
Page 34 and 35: insurance. An employee who requests
Page 36 and 37: Sources and further reading: “Obs
Page 38 and 39: independent life), an in-kind benef
Page 40 and 41: Reform of long-term care coverage A
Page 44 and 45: ciated with removing assets testing
Page 46 and 47: Sources and further reading: Depart
Page 48 and 49: coverage only to seniors enrolled i
Page 50 and 51: Pharmaceutical Policies Pharmaceuti
Page 52 and 53: eimbursement rate is 35 percent. Mo
Page 54 and 55: From 1994 to 2003, prices for all p
Page 56 and 57: keep products eligible for reimburs
Page 58 and 59: Austria: Criteria for reimbursable
Page 60 and 61: Federation of Austrian Social Secur
Page 64 and 65: Spain has now introduced a variety
Page 68 and 69: Human Resources for Health The past
Page 70 and 71: California: First-in-nation rules o
Page 74 and 75: Canada: A co-coordinated and compre
Page 76 and 77: Newsflash In this section, we follo
Page 78 and 79: ance (“Haut Conseil pour l’Aven
Page 80 and 81: law will allow some 14 percent of C
Page 82 and 83: Lieberman) proposed to finance the
Page 84 and 85: The policy emphasizes personal resp
Page 86 and 87: Canada: Independent council for qua
Page 88 and 89: New Zealand: Improving quality—a
Page 90 and 91: 1 International Monitor on Health P
Page 92 and 93: - Degree of innovation (compared wi
Page 94 and 95: 9. Long-term care: Long-term care a
Page 96 and 97: Please photocopy and fill out the f
Page 98 and 99: 6 Responsiveness to and empowerment
Page 100 and 101: Sources of information Please indic
Page 102 and 103: ❒ International organizations ❒
Page 104 and 105: Patients Civil society Private sect
Page 106 and 107: Structured summary Q 5.4 (optional)
Page 108 and 109: 7. Rating this policy (expert opini
Page 110 and 111: Call for Support International Netw
Page 112 and 113: Topics could be - Integrated care a
show all

The 2nd HPD report - Health Policy Monitor

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?